argu
arriv
articl
part
genom
emerg
infecti
diseas
plo
journal
collect
http
ploscollectionsorgemerginginfectiousdiseas
genom
era
significantli
shift
paradigm
vaccin
therapeut
develop
microbiolog
sequencebas
approach
genom
sequenc
provid
previous
unattain
rout
investig
mechan
underpin
pathogenesi
genom
transcriptom
metabolom
structur
genom
proteom
immunom
exploit
perfect
identif
target
design
new
vaccin
drug
predict
effect
patient
furthermor
human
genom
relat
studi
provid
insight
aspect
host
biolog
import
infecti
diseas
evergrow
bodi
genom
data
new
genomebas
approach
play
critic
role
futur
enabl
time
develop
vaccin
therapeut
control
emerg
infecti
diseas
control
debilit
oftenleth
infecti
diseas
vaccin
antibiot
enorm
impact
world
health
arriv
genom
era
paradigm
shift
occur
develop
vaccinesand
potenti
also
develop
antibioticsthat
provid
fresh
impetu
field
world
still
face
huge
burden
infect
howev
classic
pathogen
eg
typhoid
measl
recent
discov
caus
diseas
eg
helicobact
pylori
hepat
c
viru
hcv
emerg
infecti
diseas
eid
eg
swine
flu
sever
acut
respiratori
syndrom
coronaviru
sarscov
addit
variant
form
previous
identifi
infecti
diseas
reemerg
eg
streptococcu
pyogen
also
known
group
streptococcu
ga
dengu
fever
along
antibioticresist
form
microb
eg
methicillinresist
staphylococcu
aureu
mrsa
mycobacterium
tuberculosi
list
eid
see
http
topicsemerginglisthtm
world
health
organ
estim
expect
least
one
new
pathogen
appear
everi
year
fact
infecti
diseas
emerg
reemerg
indic
immun
infect
popul
alter
virul
potenti
increas
antibioticantivir
resist
pathogen
popul
rapid
develop
vaccin
therapeut
target
pathogen
therefor
essenti
limit
spread
tradit
empir
approach
screen
vaccin
drug
candid
time
timeconsum
often
proven
insuffici
control
mani
eid
particularli
caus
pathogen
antigen
divers
eg
hiv
cultiv
laboratori
eg
hcv
lack
suitabl
anim
model
infect
eg
neisseria
spp
complex
mechan
pathogenesi
eg
retrovirus
andor
control
mucos
celldepend
immun
respons
rather
humor
immun
respons
eg
shigella
spp
tuberculosi
mani
eid
wealth
inform
emerg
genom
era
alreadi
signific
impact
way
approach
vaccin
therapeut
develop
eid
appear
near
futur
genom
first
line
defens
term
antigen
identif
diagnost
develop
function
character
sinc
complet
genom
sequenc
haemophilu
influenzaeth
first
finish
bacteri
genom
sequencein
advanc
sequenc
technolog
bioinformat
produc
exponenti
growth
genom
sequenc
inform
least
one
genom
sequenc
avail
major
human
pathogen
octob
bacteri
genom
complet
ie
close
genom
whole
genom
shotgun
sequenc
ongo
viral
genom
complet
http
wwwgenomesonlineorggoldcgi
http
wwwncbinlmnihgovgenomesmicrobesmicrobi
taxtreehtml
http
cmrjcviorgtigrscriptscmrshar
genomescgi
bacteri
pathogen
may
gene
genom
sequenc
provid
complet
genet
repertoir
antigen
drug
target
novel
candid
identifi
viral
pathogen
may
possess
fewer
gene
genom
use
defin
variabl
may
exist
isol
host
genet
factor
also
play
role
infecti
diseas
howev
avail
complet
human
genom
sequenc
well
largescal
human
genom
project
see
http
valuabl
resourc
henc
sequenc
pathogen
host
genom
facilit
identif
grow
number
potenti
vaccin
drug
target
figur
estim
time
candid
identifi
one
two
year
use
genomicsbas
approach
identifi
convent
method
time
frame
furthermor
genomicsbas
vaccin
project
substanti
increas
understand
microbi
physiolog
epidemiolog
pathogenesi
protein
function
see
box
caus
agent
diseas
may
first
identifi
patient
sampl
use
metagenom
b
vaccin
therapeut
target
identifi
pathogen
genom
use
varieti
screen
approach
focu
genom
transcriptom
proteom
immunom
structur
genom
c
human
genom
screen
avoid
homolog
similar
pathogen
vaccin
therapeut
target
identifi
new
target
candid
vaccin
therapeut
target
identifi
must
shown
provid
protect
diseas
safe
use
patient
e
clinic
test
vaccin
therapeut
licens
use
clinic
respons
vaccin
andor
therapeut
analyz
use
human
genom
base
studi
dot
arrow
pathogen
genom
also
use
analyz
mutant
abl
evad
immun
system
vaccin
subject
organ
develop
antibiot
resist
exampl
approach
indic
given
tabl
outbreak
diseas
metagenom
studi
genet
materi
recov
directli
sampl
appli
diseas
human
sampl
aid
rapid
identif
caus
agent
complet
genom
sequenc
organ
avail
highthroughput
approach
use
screen
target
molecul
outlin
tabl
screen
approach
vari
depend
natur
pathogen
base
sever
accept
principl
key
requir
vaccin
therapeut
includ
need
target
express
access
host
immun
system
therapeut
agent
human
diseas
ii
genet
conserv
iii
import
surviv
pathogenesi
iv
free
measur
homolog
similar
host
factor
although
mani
approach
describ
focu
vaccin
develop
involv
screen
candid
immunogen
larg
applic
drug
develop
alter
select
criteria
use
screen
candid
compound
librari
idea
behind
revers
vaccinolog
screen
entir
pathogen
genom
find
gene
encod
protein
attribut
good
vaccin
target
exampl
bacteri
surfac
associ
protein
protein
undergo
normal
laboratori
evalu
immunogen
neisseria
meningitidi
serogroup
b
menb
revers
vaccinolog
project
provid
proof
concept
type
approach
project
identifi
novel
vaccin
candid
month
discov
year
convent
vaccinolog
analysi
genom
sequenc
virul
menb
strain
found
predict
open
read
frame
orf
screen
use
bioinformat
tool
identifi
orf
predict
encod
surfaceexpos
secret
protein
might
access
immun
system
antigen
screen
box
revers
vaccinolog
drive
discoveri
new
protein
function
revers
vaccinolog
involv
silico
screen
entir
genom
pathogen
find
gene
encod
protein
attribut
good
vaccin
target
use
either
genom
singl
pathogen
isol
pangenom
genom
inform
sever
isol
pathogen
speci
pili
pathogen
streptococci
play
key
role
virul
promis
vaccin
candid
identif
pili
long
filament
structur
extend
bacteri
surfac
main
pathogen
strain
streptococci
good
exampl
genom
lead
discoveri
protein
function
increas
understand
hostpathogen
interact
pili
gramneg
bacteria
welldescrib
virul
factor
littl
known
howev
pili
gramposit
bacteria
sequenc
analysi
genom
pyogen
agalactia
pneumonia
review
analysi
eight
agalactia
genom
sequenc
three
protect
antigen
identifi
pangenom
revers
vaccinolog
found
contain
lpxtg
motif
typic
cell
wallanchor
protein
seen
assembl
pili
bioinformat
analysi
reveal
three
independ
loci
encod
structur
distinct
pilu
type
contain
two
surfaceexpos
antigen
capabl
elicit
protect
immun
mice
limit
variabl
agalactia
pili
suggest
combin
three
pilin
subunit
could
lead
broad
protect
immun
follow
identif
agalactia
pili
typic
pilu
region
identifi
avail
pyogen
genom
base
presenc
gene
encod
lpxtgcontain
protein
addit
combin
recombin
pilu
protein
shown
confer
protect
mice
mucos
challeng
virul
pyogen
isol
falugi
colleagu
sinc
found
pyogen
pili
encod
nine
differ
gene
cluster
estim
vaccin
compris
combin
backbon
variant
could
provid
protect
circul
pyogen
strain
avail
multipl
complet
genom
sequenc
pneumonia
increas
understand
pilu
protein
pathogen
streptococci
led
discoveri
two
pilu
island
encod
protein
play
role
adher
lung
epitheli
cell
colon
murin
model
infect
elicit
host
inflammatori
respons
addit
pilu
subunit
confer
protect
passiv
activ
immun
model
presenc
pili
contain
protect
antigen
three
princip
streptococc
pathogen
indic
structur
play
import
role
virul
revers
vaccinolog
lead
identif
fhbp
role
meningococc
speci
specif
serogroup
b
n
meningitidi
menb
strain
respons
major
meningococc
diseas
develop
world
yet
comprehens
menb
vaccin
avail
screen
menb
genom
vaccin
candid
use
revers
vaccinolog
led
discoveri
meningococc
factor
hbind
protein
fhbp
recent
suggest
play
import
role
speci
specif
n
meningitidi
fhbp
compon
novarti
multival
menb
vaccin
enter
phase
iii
clinic
test
also
investig
wyeth
vaccin
design
group
initi
identifi
genomederiv
neisseria
antigen
neisseriaspecif
put
surfac
lipoprotein
unknown
function
fhbp
renam
abil
bind
complement
factor
h
fh
molecul
downregul
activ
complement
altern
pathway
henc
bind
fh
surfac
neisseria
allow
pathogen
evad
complementmedi
kill
innat
immun
system
fhbp
express
n
meningitidi
strain
studi
induc
high
level
bactericid
antibodi
mice
import
surviv
bacteria
human
serum
blood
discoveri
bind
fh
n
meningitidi
specif
human
fh
human
fh
alon
abl
downregul
complement
activ
bactericid
activ
lead
increas
bacteri
surviv
signific
implic
studi
organ
administr
human
fh
infant
rat
challeng
menb
led
greater
increas
surviv
bacteria
provid
import
insight
hostpathogen
interact
may
lead
develop
new
anim
model
infect
continu
basi
sever
criteria
abil
antigen
express
escherichia
coli
recombin
protein
candid
confirm
elisa
flow
cytometri
antigen
expos
cell
surfac
candid
abil
induc
antibodi
elicit
kill
measur
serum
bactericid
assay
andor
passiv
protect
infant
rat
assay
candid
screen
panel
divers
meningococc
isol
determin
whether
antigen
conserv
approach
result
develop
multicompon
recombin
menb
vaccin
enter
phase
iii
clinic
trial
multipl
genom
sequenc
becom
avail
singl
speci
concept
pangenom
revers
vaccinolog
tabl
approach
identifi
vaccin
andor
drug
target
eid
genom
era
organ
diseas
genomicsrevers
vaccinolog
analysi
genet
materi
organ
order
identifi
repertoir
protein
antigensdrug
target
organ
potenti
express
bioinformat
screen
genom
sequenc
identifi
orf
predict
expos
surfac
pathogen
secret
express
recombin
protein
gener
antibodi
mice
confirm
surfac
exposur
bactericid
activ
predict
algorithm
need
valid
nonprotein
antigen
includ
polysaccharid
glycolipid
posttransl
modif
identifi
highthroughput
clone
protein
express
requir
serogroup
b
n
meningitidi
major
caus
septicemia
mening
develop
world
pangenom
analysi
genet
materi
sever
organ
singl
speci
identifi
conserv
antigen
target
ensur
chosen
target
cover
divers
organ
similar
orf
chosen
screen
multipl
genom
either
direct
sequenc
compar
genom
hybrid
sequenc
multipl
isol
speci
requir
similar
limit
describ
agalactia
lead
caus
neonat
bacteri
sepsi
pneumonia
mening
us
europ
compar
genom
analysi
genet
materi
sever
individu
singl
speci
identifi
antigen
target
present
pathogen
strain
absent
commens
strain
thu
import
diseas
similar
pangenom
orf
chosen
screen
genom
multipl
strain
pathogen
commens
strain
speci
similar
limit
two
approach
e
coli
major
caus
mild
sever
diarrhea
hemolyticurem
syndrom
urinari
tract
infect
transcriptom
analysi
set
rna
transcript
express
organ
specifi
condit
gene
express
evalu
vitro
vivo
use
dna
microarray
cdna
sequenc
direct
correl
level
mrna
protein
vivo
studi
requir
rel
larg
amount
mrna
v
cholera
caus
diseas
rang
selflimit
sever
lifethreaten
diarrhea
wound
infect
sepsi
function
genom
analysi
role
gene
protein
order
identifi
gene
requir
surviv
specif
condit
gene
function
essenti
specif
condit
vitro
vivo
determin
gene
inhibit
follow
screen
mutant
anim
model
cell
cultur
identifi
attenu
clone
genet
tool
accept
transposon
natur
compet
pathogen
requir
h
pylori
major
caus
duoden
gastric
ulcer
stomach
cancer
result
chronic
lowlevel
inflamm
stomach
line
proteom
analysi
set
protein
express
organ
specifi
condit
andor
specif
cellular
locat
eg
cell
surfac
ms
chromatograph
techniqu
identifi
protein
whole
cell
fraction
sampl
cell
surfac
protein
low
abund
andor
solubl
protein
express
vivo
may
identifi
caus
rang
diseas
mild
pharyng
sever
toxic
shock
syndrom
necrot
fasciiti
rheumat
fever
immunom
analysi
subset
proteinsepitop
interact
host
immun
system
analysi
seroreact
protein
use
phage
display
librari
protein
microarray
probe
host
sera
bioinformat
predict
b
cell
cell
epitop
potenti
bia
sequenc
display
larg
conform
epitop
made
noncontigu
amino
acid
may
detect
predict
b
cell
epitop
difficult
due
need
identifi
conform
epitop
caus
wound
infect
emerg
signific
opportunist
pathogen
due
antibiot
resist
structur
genom
analysi
threedimension
structur
organ
protein
interact
antibodi
therapeut
nmr
crystallographi
determin
structur
protein
presenceabs
antibodi
therapeut
poor
understand
determin
immunogen
immunodomin
structurefunct
relationship
hiv
caus
agent
aid
vaccinomicsimmunogenet
pharmacogenet
analysi
human
immun
system
respond
vaccin
drug
investig
genet
heterogen
polymorph
host
individu
popul
level
may
alter
immun
respons
vaccin
metabol
therapeut
ethic
issu
person
medicin
immens
divers
human
genom
particular
human
immun
respons
emerg
power
tool
identifi
vaccin
candid
antigen
divers
speci
pangenom
aim
identifi
full
complement
gene
speci
base
superset
gene
sever
strain
speci
analysi
genom
sequenc
eight
streptococcu
agalactia
also
known
group
b
streptococcu
strain
reveal
substanti
genet
heterogen
extend
gene
repertoir
speci
screen
found
total
gene
predict
encod
surfaceexpos
secret
protein
agalactia
pangenom
core
genom
gene
conserv
strainsand
dispens
genom
gene
present
two
strain
henc
consid
dispens
surviv
base
screen
pool
candid
includ
abil
recombin
protein
provid
protect
use
immun
anim
combin
four
antigensonli
one
core
genomewa
select
shown
confer
protect
panel
agalactia
strain
wherea
genom
sequenc
project
typic
focus
pathogen
organ
comparison
genom
pathogen
nonpathogen
strain
allow
vaccin
drug
target
identifi
basi
protein
specif
involv
pathogenesi
compar
studi
commens
pathogen
e
coli
genom
identifi
gene
uniqu
certain
pathogen
strain
larg
absent
commens
strain
filter
decreas
pool
target
screen
potenti
limit
detriment
effect
therapeut
composit
commens
flora
new
sequenc
technolog
also
open
opportun
monitor
pathogen
vaccin
escap
screen
evid
immun
select
genom
pathogen
popul
vaccin
select
deepsequenc
bacteri
viral
popul
possibl
identifi
antigen
immun
select
monitor
cluster
singl
nucleotid
polymorph
snp
mutat
affect
protein
sequenc
approach
alreadi
use
search
evid
antigen
variationselect
popul
salmonella
enterica
serovar
typhi
variat
extrem
limit
similar
sequenc
strategi
could
appli
popul
bacteria
taken
vaccin
trial
particular
geograph
region
pathogen
gene
upregul
infect
andor
essenti
microorgan
surviv
pathogenesi
identifi
use
transcriptom
ie
analysi
near
complet
set
rna
transcript
express
pathogen
specifi
condit
comprehens
dnabas
microarray
chip
probe
cdna
gener
rna
revers
transcript
ultrahighthroughput
sequenc
technolog
allow
rapid
sequenc
direct
quantif
cdna
enabl
transcriptom
pathogen
character
particular
type
gene
product
identifi
exampl
gene
involv
hyperinfecti
state
vibrio
cholera
appear
passag
human
gastrointestin
tract
identifi
comparison
transcriptom
bacteria
isol
directli
stool
sampl
cholera
patient
v
cholera
grown
vitro
similarli
analysi
transcript
profil
tuberculosi
earli
infect
immunecompet
balbc
sever
combin
immunodefici
scid
mice
reveal
set
gene
activ
exclus
respons
host
immun
system
function
genomicslink
genotyp
transcriptom
proteom
phenotypeha
appli
mani
pathogen
identifi
gene
essenti
surviv
virul
may
valid
vaccin
candid
dna
microarray
use
screen
comprehens
librari
pathogen
mutant
compar
bacteri
isol
passag
anim
model
exposur
compound
librari
identifi
attenu
clone
exampl
method
use
identifi
novel
menb
gene
requir
pathogen
caus
septicemia
infant
rat
gene
essenti
h
pylori
gastric
colon
gerbil
gene
contribut
tuberculosi
persist
host
analysi
pathogen
proteom
near
complet
set
protein
express
specifi
condit
reveal
potenti
vaccin
drug
candid
add
signific
valu
silico
approach
highthroughput
proteom
analys
perform
use
mass
spectrometri
ms
chromatograph
techniqu
protein
microarray
novel
proteomebas
approach
appli
identifi
surfac
protein
ga
make
use
proteolyt
enzym
shave
bacteri
surfac
releas
expos
protein
partial
expos
peptid
seventeen
surfac
protein
virul
ga
strain
identifi
way
use
ms
genom
sequenc
analysi
locat
pathogen
surfac
confirm
flow
cytometri
one
provid
protect
immun
mous
model
diseas
proteom
pathogen
also
screen
identifi
immunom
near
complet
set
pathogen
protein
epitop
interact
host
immun
system
use
vitro
silico
techniqu
vitro
identif
screen
immunom
base
idea
antibodi
present
serum
host
expos
pathogen
repres
molecular
imprint
pathogen
immunogen
protein
use
identifi
vaccin
candid
sever
techniqu
develop
allow
highthroughput
display
pathogen
protein
subsequ
screen
protein
interact
antibodi
sera
immunogen
surfac
protein
sever
organ
identifi
includ
aureu
use
membran
blot
ms
agalactia
pyogen
streptococcu
pneumonia
use
phageor
e
colibas
comprehens
genom
peptid
express
librari
francisella
tularensi
caus
agent
tularemia
rabbit
fever
v
cholera
use
protein
microarray
chip
protein
microarray
protein
pathogen
spot
onto
microarray
chip
also
use
character
proteindrug
interact
well
proteinprotein
proteinnucl
acid
ligandreceptor
enzymesubstr
interact
abil
predict
silico
pathogen
epitop
recogn
b
cell
cell
greatli
improv
recent
year
largescal
screen
pathogen
includ
hiv
bacillu
anthraci
tuberculosi
f
tularensi
yersinia
pesti
caus
agent
bubon
plagu
flavivirus
influenza
b
cell
cell
epitop
current
underway
although
epitop
predict
foolproof
serv
guid
biolog
evalu
cell
epitop
present
mhchla
protein
surfac
antigenpres
cell
vari
consider
host
complic
task
function
epitop
predict
addit
b
cell
epitop
linear
conform
ultim
aim
research
field
studi
would
engin
singl
peptid
repres
defin
epitop
combin
protein
organ
enabl
genet
variabl
pathogen
host
overcom
structur
genomicsth
studi
threedimension
structur
protein
produc
speciesi
increasingli
appli
vaccin
drug
develop
result
explos
genom
proteom
data
continu
improv
field
protein
express
purif
structur
determin
structurebas
design
antivir
therapeut
led
develop
drug
direct
activ
site
proteas
influenza
neuraminidas
highresolut
protein
structur
avail
public
databas
see
http
www
wwpdborgstatshtml
sever
initi
establish
pursu
highthroughput
character
protein
structur
genomewid
scale
focus
determin
understand
structur
basi
immunedomin
immunerecess
antigen
well
protein
activ
site
potenti
drugbind
site
exampl
structur
character
hiv
envelop
protein
reveal
mechan
use
viru
evad
host
antibodi
respons
mani
involv
hypervari
immunodomin
epitop
base
inform
immun
refocus
eg
retarget
glycosyl
delet
andor
substitut
amino
acid
use
dampen
respons
variabl
immunodomin
epitop
envelop
glycoprotein
enabl
host
respond
previous
subdomin
epitop
highthroughput
modif
protein
screen
immunogen
interact
antimicrobi
predict
becom
common
techniqu
evolv
design
new
vaccin
one
import
consider
risk
vaccin
might
gener
self
immun
reaction
host
epitop
immun
respons
pathogen
antigen
crossreact
host
antigen
homolog
exist
primari
amino
acid
sequenc
structur
potenti
lead
damag
host
tissu
drug
aim
pathogen
target
could
also
theoret
target
similar
host
molecul
avail
human
genom
sequenc
combin
method
predict
b
cell
cell
epitop
facilit
screen
presenc
homolog
candid
microbi
vaccin
antigen
protein
human
enabl
issu
autoimmun
crossreact
tackl
vaccin
drug
target
identifi
use
method
base
pathogen
genom
screen
homolog
similar
human
protein
silico
use
program
blast
basic
local
align
search
tool
http
blastncbinlmnihgov
blastcgi
queri
human
genom
databas
interestingli
analysi
viral
genom
reveal
around
viral
pentapeptid
could
compon
epitop
ident
human
peptid
littl
homolog
howev
valid
immunogen
diseaseassoci
peptidesepitop
host
peptid
suggest
screen
approach
includ
predict
immunogen
could
improv
pool
target
candid
import
keep
mind
fulli
understand
selftoler
broken
current
perfect
way
predict
potenti
autoimmun
trigger
could
associ
vaccin
mani
link
made
autoimmun
diseas
vaccin
confirm
small
number
case
review
exampl
treatmentresist
lyme
arthriti
associ
certain
patient
immun
reactiv
outer
surfac
protein
ospa
caus
agent
lyme
diseas
borrelia
burgdorferi
ospa
epitop
homolog
human
lymphocyt
functionassoci
antigen
hlfa
result
ospabas
lyme
diseas
vaccin
lymerix
taken
market
recombin
ospa
lack
potenti
autoreact
cell
epitop
propos
replac
vaccin
rather
target
drug
pathogen
enzym
altern
approach
focus
target
hostcel
protein
exploit
pathogen
replic
surviv
use
techniqu
includ
microarraybas
analysi
virusinduc
host
gene
express
reveal
sever
possibl
target
cholesterollow
drug
statin
exampl
antihiv
effect
believ
mediat
prevent
activ
host
protein
rho
activ
hiv
envelop
protein
requir
viru
entri
cell
furthermor
studi
improv
understand
host
immun
respons
protect
pathogen
ie
innat
antibodi
respons
aid
select
appropri
vaccin
adjuv
exampl
induct
interferon
signal
earli
infect
may
critic
confer
protect
sarscov
determin
function
genom
studi
earli
host
respons
sarscov
infect
lung
macaqu
mani
gene
human
immun
system
highli
polymorph
enabl
popul
whole
gener
suffici
immunolog
divers
combat
eid
variat
also
impact
outcom
vaccin
treatment
intern
hapmap
project
identifi
million
snp
individu
genom
project
aim
identifi
even
genet
variant
field
vaccinom
also
call
immunogenet
investig
heterogen
host
genet
marker
result
variat
vaccineinduc
immun
respons
aim
predict
minim
vaccin
failur
advers
event
exampl
polymorph
hla
immunoregulatori
cytokin
receptor
gene
associ
variabl
outcom
vaccin
mump
similarli
pharmacogenet
investig
genet
differ
way
individu
metabol
therapeut
found
human
variabl
speed
metabol
common
firstlin
tuberculosi
drug
isoniazid
associ
genet
variant
includ
snp
gene
encod
arylamin
nacetyltransferas
abil
predict
individu
respons
vaccin
drug
may
eventu
allow
physician
determin
whether
patient
genet
suscept
diseas
possibl
advers
effect
vaccin
drug
appropri
schedul
dose
use
predict
genom
greatli
aid
control
eid
increas
effici
vaccin
therapeut
target
identifi
use
genomebas
approach
describ
furthermor
anticip
continu
refin
develop
novel
genomebas
approach
sequenc
becom
faster
afford
sever
challeng
remain
howev
identif
target
process
need
bring
new
vaccin
drug
market
understand
molecular
natur
epitop
mechan
action
adjuv
cell
mucos
immun
key
prioriti
tackl
come
year
issu
address
improv
structur
studi
antigen
epitop
compil
databas
contain
inform
structur
immunogen
silico
b
cell
cell
epitop
predict
genomebas
develop
effect
vaccin
therapeut
still
larg
depend
avail
valid
model
measur
efficaci
protect
diseas
howev
increas
understand
microbi
pathogenesi
emerg
genom
greatli
aid
respect
likewis
continu
develop
anim
model
knockout
allelespecif
mutat
key
compon
immun
respons
greatli
increas
understand
type
immun
respons
need
control
diseas
way
immun
system
program
protect
host
diseas
unfortun
stepwis
seri
prelicensur
clinic
trial
phase
ii
iii
requir
document
safeti
immunogen
efficaci
vaccin
still
highli
timeconsum
costli
hope
increasingli
smart
identif
design
target
fresh
impetu
given
field
vaccin
drug
develop
arriv
genom
enabl
increas
success
vaccin
drug
make
clinic
develop
